drugset
drugset / Trial / NCT02313194

Spinal Cord Neuromodulation for Spinal Cord Injury

NCT02313194 ↗

Phase 1/2 Active not recruiting 12 enrolled University of California, Los Angeles
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.

Timeline

Start
2013-07
Primary completion
2026-06-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule — —

Indications

quadriplegia spinal cord injury